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days postintervention. Numerous publications in various
different disciplines have recently demonstrated that 30-
day mortality rates do not sufficiently capture death related
to the procedure in specific subsets of patients and causes of
death. In this issue of the Journal, Pezzi and colleagues1
examined 114,905 patients who had undergone major pul-
monary resection for lung cancer in 1233 hospitals from
the US National Cancer Data Base over a 5-year period
and looked at 30-day, conditional 90-day, and 90-day mor-
tality, and their relationship to hospital volume.
In this cross-sectional study, the 90-day mortality (5.4%)
was approximately double the 30-day mortality (2.8%).
Low hospital volume for major pulmonary resection was
significantly associated with increased 30-day, conditional
90-day, and 90-day mortality. Hospitals performing less
than 30 resections per year had a more than 3% unadjusted
30-day mortality compared with 1.7% in those performing
more than 90 cases per year. This is not surprising. Region-
alization of lung cancer care to high-volume centers2,3 and
high-volume surgeons4 has been shown to decrease periop-
erative morality and even long-term mortality. The majority
of studies looking at hospital and surgeon volume and mor-
tality rates examined perioperative mortality using the 30-
day definition. An important point to keep in mind when
reading the article is that high and low volume were defined
using what most thoracic oncologists would consider very,
very low volume (<10 and<30 cases per year, respec-
tively). Nine percent of resections were performed in hospi-
tals with an annual surgical volume of less than 10 cases per
year, 45% of cases were performed in hospitals performing
less than 30 cases per year, and the median annual volume
was very low at 33 cases per year.From the University of Montreal, Montreal, Quebec, Canada.
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are related not only to surgeon volume but also to hospital
expertise, hospital resources, dedicated and specialized
nurses, physiotherapists, respiratory technicians, specialized
equipment, multidisciplinary oncology teams, surgeon
training, specialized thoracic anesthesiologists, thoracic sur-
gery intensive care expertise, teams of surgeons who are
able to cover call and deal with complications 24 hours a
day, 7 days a week, 365 days a year, and experienced house
staff and fellow coverage.5-7 These elements are difficult to
isolate because of the complex interplay among them. To
include all of these important elements in a hospital, a large
volume of pulmonary resections are necessary to attract
surgeons and allied health professionals and allow for a
hospital or payer system to have a positive return on its
investment.
So, if your car was broken, would you take it to a garage
that fixed less than 10 cars a year? There is no question that
the regionalization of the surgical care of lung cancer would
be an effective way to improve patient outcomes and prob-
ably decrease costs. The question remains, is the regionali-
zation of lung cancer care practical, feasible, and politically
possible?
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